Extensive research has been conducted on the safety and feasibility of OS during gynecological surgeries. It has been proven that OS is safe when performed during gynecological procedures, with no increase in surgical complications, and that operative time increases by only a few minutes when OS is added. (1–5)

As a result, OS is now recommended in several clinical guidelines, including the Netherlands. (6)

References

1. Song T, Kim MK, Kim ML, Jung YW, Yun BS, Seong SJ, et al. Impact of opportunistic salpingectomy on anti-Müllerian hormone in patients undergoing laparoscopic hysterectomy: a multicentre randomised controlled trial. 2017;124(2):314-20.

2. Van Lieshout LAM, Pijlman B, Vos MC, de Groot MJM, Houterman S, Coppus S, et al. Opportunistic salpingectomy in women undergoing hysterectomy: Results from the HYSTUB randomised controlled trial. 2018;107:1-6

3. Yoon SH, Kim SN, Shim SH, Kang SB, Lee SJ. Bilateral salpingectomy can reduce the risk of ovarian cancer in the general population: A meta-analysis. Eur J Cancer. 2016;55:38-46.

4. Antosh DD, High R, Brown HW, Oliphant SS, Abed H, Philip N, et al. Feasibility of prophylactic salpingectomy during vaginal hysterectomy. Am J Obstet Gynecol. 2017;217(5):605.e1-.e5.

5. Magarakis L, Idahl A, Särnqvist C, Strandell A. Efficacy and safety of sterilisation procedures to reduce the risk of epithelial ovarian cancer: a systematic review comparing salpingectomy with tubal ligation. Eur J Contracept Reprod Health Care. 2022;27(3):230-9.

6.  Het vergrote ovarium, richtlijn Opportunistische Slapingectomie Federatie Medisch Specialisten:  Opportunistische Salpingectomie - Richtlijn - Richtlijnendatabase